home / stock / fbio / fbio quote
Last: | $1.76 |
---|---|
Change Percent: | 0.0% |
Open: | $1.69 |
Close: | $1.76 |
High: | $1.85 |
Low: | $1.67 |
Volume: | 188,762 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.76 | $1.69 | $1.76 | $1.85 | $1.67 | 188,762 | 07-04-2024 |
$1.76 | $1.69 | $1.76 | $1.85 | $1.67 | 188,762 | 07-03-2024 |
$1.67 | $1.66 | $1.67 | $1.68 | $1.62 | 109,122 | 07-02-2024 |
$1.69 | $1.75 | $1.69 | $1.75 | $1.67 | 81,683 | 07-01-2024 |
$1.71 | $1.67 | $1.71 | $1.71 | $1.62 | 179,488 | 06-28-2024 |
$1.68 | $1.7 | $1.68 | $1.71 | $1.6 | 269,922 | 06-27-2024 |
$1.7 | $1.68 | $1.7 | $1.72 | $1.68 | 98,599 | 06-26-2024 |
$1.69 | $1.72 | $1.69 | $1.74 | $1.675 | 162,766 | 06-25-2024 |
$1.7 | $1.78 | $1.7 | $1.78 | $1.7 | 94,994 | 06-24-2024 |
$1.77 | $1.71 | $1.77 | $1.79 | $1.65 | 181,897 | 06-21-2024 |
$1.71 | $1.81 | $1.71 | $1.8499 | $1.66 | 384,691 | 06-20-2024 |
$1.79 | $1.9 | $1.79 | $1.96 | $1.78 | 273,260 | 06-19-2024 |
$1.79 | $1.9 | $1.79 | $1.96 | $1.78 | 273,260 | 06-18-2024 |
$1.9 | $1.89 | $1.9 | $2.05 | $1.87 | 641,903 | 06-17-2024 |
$1.87 | $1.93 | $1.87 | $1.9499 | $1.84 | 176,428 | 06-14-2024 |
$1.97 | $1.98 | $1.97 | $1.99 | $1.9 | 123,929 | 06-13-2024 |
$1.99 | $1.96 | $1.99 | $2.03 | $1.95 | 184,397 | 06-12-2024 |
$1.97 | $1.94 | $1.97 | $1.97 | $1.87 | 82,172 | 06-11-2024 |
$1.96 | $1.83 | $1.96 | $2.01 | $1.76 | 583,036 | 06-10-2024 |
$1.8 | $1.76 | $1.8 | $1.82 | $1.76 | 81,644 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
Fortress Biotech Inc. Company Name:
FBIO Stock Symbol:
NASDAQ Market:
Fortress Biotech Inc. Website:
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has entered into a definitive agreement with a single healthcare-dedicated institutional in...
WALTHAM, Mass., July 02, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has completed the resubmission of its Biologics License Application (“BLA”) t...
WALTHAM, Mass., June 24, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced it has reached alignment with the Food and Drug Administration (“FDA”) on its bi...